These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7687205)

  • 1. Analytical performance goals for measuring prostate-specific antigen.
    Fritsche HA; Babaian RJ
    Clin Chem; 1993 Jul; 39(7):1525-7; discussion 1527-9. PubMed ID: 7687205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variance function as basis for assessment of test performance: methodological studies with two assays of prostate-specific antigen.
    Hänseler E; Keller B; Keller H
    Clin Chem; 1994 Nov; 40(11 Pt 1):2046-52. PubMed ID: 7525116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.
    Ishikawa T; Yoneyama T; Tobisawa Y; Hatakeyama S; Kurosawa T; Nakamura K; Narita S; Mitsuzuka K; Duivenvoorden W; Pinthus JH; Hashimoto Y; Koie T; Habuchi T; Arai Y; Ohyama C
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of prostate-specific antigen in serum by immunoradiometric assay.
    Lindstedt G; Jacobsson A; Lundberg PA; Hedelin H; Pettersson S; Unsgaard B
    Clin Chem; 1990 Jan; 36(1):53-8. PubMed ID: 1688745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suitability of quality control materials for prostate-specific antigen (PSA) measurement: inter-method variability of common tumor marker control materials.
    Vucetic Z; Dnistrian A; Nilsson O; Lilja HG; Plebani M
    Clin Chem Lab Med; 2013 Apr; 51(4):873-80. PubMed ID: 23314549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml.
    Martínez-Piñeiro L; Tabernero A; Contreras T; Madero R; Lozano D; López-Tello J; Alonso-Dorrego JM; Picazo ML; González Gancedo P; Martínez-Piñeiro JA; de La Peña JJ
    Eur Urol; 2000 Mar; 37(3):289-96. PubMed ID: 10720854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification analyses for prostate cancer, benign prostate hyperplasia and healthy subjects by SERS-based immunoassay of multiple tumour markers.
    Zhou L; Liu Y; Wang F; Jia Z; Zhou J; Jiang T; Petti L; Chen Y; Xiong Q; Wang X
    Talanta; 2018 Oct; 188():238-244. PubMed ID: 30029370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical goals developed from the inherent error of medical tests.
    Ross JW; Fraser MD
    Clin Chem; 1993 Jul; 39(7):1481-93; discussion 1493-4. PubMed ID: 8330410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of the PSA-concentration for the detection of prostate cancer].
    Stachon A
    Pathologe; 2005 Nov; 26(6):469-72. PubMed ID: 16195861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new quality control model using performance goals based on biological variation in External Quality Assurance Schemes.
    Mina A
    Clin Chem Lab Med; 2006; 44(1):86-91. PubMed ID: 16375592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.
    Hagiwara K; Tobisawa Y; Kaya T; Kaneko T; Hatakeyama S; Mori K; Hashimoto Y; Koie T; Suda Y; Ohyama C; Yoneyama T
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134773
    [No Abstract]   [Full Text] [Related]  

  • 12. Is free prostate-specific antigen helpful in the differential diagnosis of benign hyperplasia and cancer of the prostate?
    Reiter W; Stieber P; Schmeller N; Nagel D; Schambeck C; Fateh-Moghadam A
    Tumour Biol; 1997; 18(2):80-7. PubMed ID: 9222305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of novel electrochemical immunosensor for detection of prostate specific antigen using ferrocene-PAMAM dendrimers.
    Çevik E; Bahar Ö; Şenel M; Abasıyanık MF
    Biosens Bioelectron; 2016 Dec; 86():1074-1079. PubMed ID: 27641479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasensitive electrochemical immunosensor for PSA biomarker detection in prostate cancer cells using gold nanoparticles/PAMAM dendrimer loaded with enzyme linked aptamer as integrated triple signal amplification strategy.
    Kavosi B; Salimi A; Hallaj R; Moradi F
    Biosens Bioelectron; 2015 Dec; 74():915-23. PubMed ID: 26257183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
    Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
    JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation of free and total prostate-specific antigen levels: the effect on the percent free/total prostate-specific antigen.
    Nixon RG; Lilly JD; Liedtke RJ; Batjer JD
    Arch Pathol Lab Med; 1997 Apr; 121(4):385-91. PubMed ID: 9140308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference material for PSA: the IFCC standardization study. International Federation of Clinical Chemistry.
    Stamey TA; Chen Z; Prestigiacomo AF
    Clin Biochem; 1998 Aug; 31(6):475-81. PubMed ID: 9740969
    [No Abstract]   [Full Text] [Related]  

  • 18. Two-Stage Biomarker Protocols for Improving the Precision of Early Detection of Prostate Cancer.
    Barnett CL; Tomlins SA; Underwood DJ; Wei JT; Morgan TM; Montie JE; Denton BT
    Med Decis Making; 2017 Oct; 37(7):815-826. PubMed ID: 28363265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future directions regarding quality assurance and standardization of prostate specific antigen immunoassays.
    Nakamura RM
    Cancer; 1994 Sep; 74(6):1655-9. PubMed ID: 7521781
    [No Abstract]   [Full Text] [Related]  

  • 20. Analytical performance of the Tandem-R free PSA immunoassay measuring free prostate-specific antigen.
    Woodrum DL; French CM; Hill TM; Roman SJ; Slatore HL; Shaffer JL; York LG; Eure KL; Loveland KG; Gasior GH; Southwick PC; Shamel LB
    Clin Chem; 1997 Jul; 43(7):1203-8. PubMed ID: 9216457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.